Progression in Fontan conduit stenosis and hemodynamic impact during childhood and adolescence

Neil D Patel1, Connie Friedman2, Cynthia Herrington3

  • 1Division of Pediatric Cardiology, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, Calif.

Insights

Fontan conduit cross-sectional area (CSA) significantly decreases within months after surgery. Smaller conduit CSA correlates with reduced exercise capacity but not cardiac output or pulmonary artery growth.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Cardiac Surgery

Background:

  • The Fontan procedure is a palliative surgery for single-ventricle congenital heart defects.
  • Long-term outcomes and conduit health are critical for Fontan physiology patients.

Purpose of the Study:

  • To analyze changes in Fontan conduit cross-sectional area (CSA) over time.
  • To investigate the relationship between Fontan conduit CSA and cardiac output, pulmonary artery growth, and exercise capacity.

Main Methods:

  • Retrospective cross-sectional study of 158 patients with extracardiac Fontan.
  • Cardiac MRI or catheterization data collected between 2013-2019.
  • Analysis of Fontan conduit CSA, Nakata index, cardiac index, and exercise capacity.

Main Results:

  • Minimum Fontan conduit CSA decreased by a median of 33% within 9.6 years post-surgery.
  • Conduit size reduction was observed as early as 6 months post-Fontan.
  • A larger Fontan CSA showed a modest correlation with improved exercise capacity (% predicted oxygen consumption).

Conclusions:

  • Fontan conduit CSA diminishes early in the post-operative period.
  • Fontan conduit CSA was not associated with cardiac index or pulmonary artery size.
  • Fontan conduit CSA correlates with exercise capacity in patients with Fontan physiology.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
185
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
190
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
228
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
160
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
377
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
102